Scientists are getting closer to understanding the wasting and fatigue that often accompanies cancer. Treatments could be on ...

Cachexia—a syndrome characterized by progressive muscle wasting—affects both humans and dogs with chronic diseases such as ...

Cachexia-a syndrome characterized by progressive muscle wasting-affects both humans and dogs with chronic diseases such as cancer.

Cachexia—a syndrome characterized by progressive muscle wasting—affects both humans and dogs with chronic diseases such as cancer. A recent study in ...

Lkb1-mutant lung tumors release prostaglandin E2, triggering signaling via lung sensory neurons and the vagus nerve to reduce ...

The biotech’s potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.

Cachexia is a condition in which patients affected by cancer or other chronic diseases become sick and lose weight.

Cachexia is a condition in which patients affected by cancer or other chronic diseases become sick and lose weight. The ...

A new therapeutic target for treating sarcopenia, the age-related loss of muscle mass, and cachexia, the severe muscle ...

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle ...

NRAS-, and BRAF-mutant models, including colorectal, lung, and melanoma, by resisting the RAF-mediated bypass signaling that has constrained other MEK inhibitors - - In head-to-head in vivo studies, ...